Bacitracin/lidocaine/polymyxin b

Rabbit anti Human JMJD6 Antibody, Polyclonal, could be used for WB and so on.ApplicationWB: 0.01-2µg/mLFunctionDioxygenase that can both act as a histone arginine demethylase and a lysyl-hydroxylase. Acts as a lysyl-hydroxylase that catalyzes

Rabbit anti Human JMJD6 Antibody, Polyclonal, could be used for WB and so on.ApplicationWB: 0.01-2µg/mLFunctionDioxygenase that can both act as a histone arginine demethylase and a lysyl-hydroxylase. Acts as a lysyl-hydroxylase that catalyzes

L-Biopterin is the oxidized form of BH4, a NOS cofactor. L-Biopterin can be reduced to BH4 via thioredoxin reductase followed by dihydropteridine reductase or reduced glutathione.

L-Biopterin is the oxidized form of BH4, a NOS cofactor. L-Biopterin can be reduced to BH4 via thioredoxin reductase followed by dihydropteridine reductase or reduced glutathione.

A positional isomer of LXA4 produced by the metabolism of 15-HETE or 15-HpETE by human leukocytes inhibits PMV migration stimulated by LTB4 at a concentration of 10-7 M and inhibits LTB4-induced adhesion of PMNs with an IC₅₀ value of ~3

Lonigutamab (anti-IGF1-R) is a humanized monoclonal antibody against the insulin-like growth factor-1 receptor (IGF-1R) with the potential to treat thyroid eye disease (TED).

Lonigutamab (anti-IGF1-R) is a humanized monoclonal antibody against the insulin-like growth factor-1 receptor (IGF-1R) with the potential to treat thyroid eye disease (TED).

Lonigutamab (anti-IGF1-R) is a humanized monoclonal antibody against the insulin-like growth factor-1 receptor (IGF-1R) with the potential to treat thyroid eye disease (TED).

Lonigutamab (anti-IGF1-R) is a humanized monoclonal antibody against the insulin-like growth factor-1 receptor (IGF-1R) with the potential to treat thyroid eye disease (TED).

Application LY-411575 has been used as a potent &#947:-secretase inhibitor and Notch inhibitor. Biochem/physiol Actions LY-411575 is potent, cell permeable and selective &#947:-secretase inhibitor that reduces A&#946:/42 after acute or

Application LY-411575 has been used as a potent &#947:-secretase inhibitor and Notch inhibitor. Biochem/physiol Actions LY-411575 is potent, cell permeable and selective &#947:-secretase inhibitor that reduces A&#946:/42 after acute or

LY3022855 (anti-CSF1R) is a recombinant, immunoglobulin, human monoclonal antibody directed against colony stimulating factor 1 receptor (CSF1R) with potential antineoplastic activity.